Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Melanoma 15Neoplasm Metastasis 11Ovarian Neoplasms 9Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 6Skin Neoplasms 6Leukemia, Myeloid, Acute 6Colorectal Neoplasms 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 4Gastrointestinal Neoplasms 4Breast Neoplasms 4Vulvar Neoplasms 3Uterine Cervical Neoplasms 3Urogenital Neoplasms 3Rectal Neoplasms 3Neuroblastoma 3Myelodysplastic Syndromes 3Multiple Myeloma 3Leukemia 3Colonic Neoplasms 3Vaginal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Penile Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms 2

Interventions

fludarabine 7Whole-Body Irradiation 6Cyclophosphamide 6venetoclax 5fludarabine phosphate 5Tacrolimus 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Busulfan 4asciminib 3gilteritinib 2blinatumomab 2aldesleukin 2Patient Reported Outcome Measures 2Mesna 2Melphalan 2Interleukin-2 2Idarubicin 2Cytarabine 2Bone Marrow Transplantation 2Azacitidine 2ponatinib 1nilotinib 1nicotinamide-beta-riboside 1methanesulfonic acid 1enasidenib 1Thiotepa 1Stem Cell Transplantation 1Social Determinants of Health 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid × aldesleukin × 1 year × Clear all
NCT06152809 2026-03-18

CIML NK Cells With Venetoclax for AML

Dana-Farber Cancer Institute

Phase 1 Recruiting
10 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT06138587 2026-01-02

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Dana-Farber Cancer Institute

Phase 1 Recruiting
15 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡